BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Participate in Breakthrough for Brain Tumors(R) 5K Run

Oct 10, 2022

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that its Chief Executive Officer John Climaco will participate in The American Brain Tumor Association’s Breakthrough for Brain Tumors(R) 5K Run. The event is taking place on Saturday, Nov. 5, 2022, in Los Angeles, California. “The unmet need in brain tumor treatment is immense and knows no geographic borders. As CEO of CNS, I have come to know many brain tumor patients personally and the optimism and strength with which they have all faced this terrible diagnosis is a continuing source of inspiration to me. Supporting these patients, their journey and the challenges they currently endure is not just a priority for us, it is why we do what we do,” Climaco said. “Across the globe there is an urgent need for safe and effective GBM treatment options, and I am proud to participate in the BT5K to support the mission of the ABTA, to help bring hope to patients and families and to raise much needed funds for research.”

To view the full press release, visit https://ibn.fm/e1CPq

About CNS Pharmaceuticals Inc.

CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The company’s lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is currently in development for the treatment of a number of serious brain and CNS oncology indications including glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Additionally, the company is advancing the development of its WP1244 drug technology portfolio, which utilizes anthracycline and distamycin-based scaffolds to create small molecule agents and is believed to be 500x more potent than daunorubicin in inhibiting tumor cell proliferation. Preclinical studies of WP1244 demonstrated high uptake in the brain with antitumor activity. CNS Pharmaceuticals is evaluating the use of the WP1244 portfolio in the treatment of brain cancers, pancreatic, ovarian, and lymphomas. For more information, visit the company’s website at www.CNSPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at https://ibn.fm/CNSP

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]

BioMedWire is part of the InvestorBrandNetwork

More News

Putting skin recovery at the heart of beauty care

Oct 30, 2026

Putting skin recovery at the heart of beauty care

Skin recovery took center stage at a gathering of dermatologists, cosmetic surgeons and aesthetic practitioners in Taguig City, where a discussion on barrier care connected skincare science with the experiences and professional interests of the medical community. Held on October 21 at the Intramuros Tent of Manila House Private Club in Bonifacio Global City, the roundtable discussion brought together the Pan Pacific Aesthetic Institute Foundation, Lamelex, Golden Visa Central and Manila House. Their collaboration provided a setting for scientific learning, professional exchange and conversations about opportunities beyond clinical practice. For the beauty discussion, the emphasis was on caring for the skin barrier, particularly after dermatologic and aesthetic procedures. Dr. Finesse Angelica Evangelista addressed this in her presentation, “The Science of Recovery: Optimizing Barrier Repair in Post-Procedure and Compromised Skin.” Her discussion underscored the importance of skin barrier integrity in supporting recovery. It also placed barrier-focused care within a professional conversation about the needs of skin following procedures or when its condition is compromised. That focus is central to Lamelex’s approach. The brand presented its multi-lamellar vesicle technology, a skincare delivery approach designed to support the skin’s natural barrier structure and in­gre­­­­d­ient delivery. Its professional skincare offe­rings combine formulations and protocols intended for barrier-focused care. The technology formed part of the brand’s showcase, which included professional skincare products, testers, merchandising and educational materials. These gave participants opportunities to explore its approach to skin barrier care alongside the scientific discussion. Medical professionals also received product kits for further exploration and evaluation in their respective practices. Catherine Andres-Gamo, chief exe­cutive officer of Pretty Skin Lamelin Philippines, expanded the conversation from products to advocacy. Sha­ring Lamelex’s commitment to scientific education, skincare innovation and collaboration with the medical community, she encouraged participants to become skin barrier advocates. Her message called for greater awareness of barrier-first skincare in clinical practice, linking the brand’s educational efforts with the professionals who assess and care for patients’ skin. The evening brought that advocacy into direct conversation with dermatologists, cosmetic surgeons and other aesthetic practitioners. The foundation, meanwhile, provided a platform for professional exchange within the aesthetic medical community. Manila House hosted the gathering, bringing professionals from different fields into a shared setting for learning and relationship building. Alongside the skincare discussions, Golden Visa Central founder and president Vicky Luis introduced international investment opportunities and wealth diversification. Her presentation offered participants perspectives on long-term financial planning beyond their clinical work, extending the evening’s scope to their broader professional and personal interests. The gathering linked these different areas through partnerships among the foundation’s leadership, Golden Visa Central, Manila House and the Lamelex team. Each contributed expertise to a forum that combined clinical interests with opportunities for professional growth. For Lamelex, the continuing direction is to build its community of skin barrier advocates through scientific education and continued collaboration with medical professionals. The roundtable provided one setting for that exchange, bringing its products, technology and barrier-care message to practitioners who could explore and evaluate them for use in their respective practices.

Jewelry for every side of a woman

Oct 30, 2026

Jewelry for every side of a woman

Jewelry passed from mother to daughter carries more than gemstones and gold. For designer Kristine Dee, it also holds the stories behind each piece, including her mother’s purchase to celebrate a hard-earned business deal. Those personal connections inspire “Modern Heirloom,” one of three chapters in “The Woman Within,” her collection exploring the different sides of a woman through fine jewelry. Its three chapters, “Modern Heirloom,” “Quiet Strength” and “Playful Femininity,” move from sentiment to assurance to joy. Each reflects a side of a woman that Dee has observed in her clients and herself. “They try out other styles which are not their usual, and the choice follows their emotions, what they felt at that time, how that particular jewelry piece made them feel when worn. Each capsule collection shows the different versions we, as women, find ourselves in.” For “Modern Heirloom,” Dee draws on her mother Elizabeth’s practice of passing jewelry to her daughters, along with the memories behind it. Among them is a piece Elizabeth bought after closing a business deal she had worked hard to secure. “It is not just the piece that she shared, but the story that comes with them,” Dee says. That sense of continuity takes shape in classic gemstones and versatile designs. Multicolored sapphire and diamond necklaces hang from substantial gold-ball chains. A pearl necklace features diamonds and a detachable kunzite centerpiece, allowing the wearer to move between dressier and more casual looks. “Quiet Strength” turns toward architecture, emphasizing line, proportion and structure. Smooth gold surfaces, curves and carefully placed diamonds give rings and cuffs their presence. Dee’s background in industrial design informs this attention to form and how a piece sits on the body. “Each millimeter matters,” she says. A softer mood emerges in “Playful Femininity.” Mint tourmaline, pink spinel and diamonds appear in linked elements that sway with the wearer, while a coordinating ring allows for stacking. Elsewhere, a hand-carved mother-of-pearl ribbon flows into waves of rubies and diamonds. Across the collection, gemstones are set in 14-karat and 18-karat white, yellow and rose gold. Many designs bear the names of loyal clients, relatives and friends, extending the personal connections behind the jewelry. For Dee, their place is in everyday wardrobes. Statement necklaces can accompany a tank top and jeans or a dress, while rings and cuffs can be layered to suit the day. “The best way to style fine jewelry for a woman is based on her lifestyle and personality, so she can reach for them day after day, comfortably and confidently, and wear them in more ways than one.” The collection is available at the Kristine Dee showroom in BGC, Taguig City, with resizing and customization offered. A Power Plant Mall pop-up runs from Nov. 7 to Jan. 28, 2027, bringing the collection’s expressions of memory, strength and joy into women’s daily choices.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.